Literature DB >> 11093145

Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes.

R Lapointe1, J F Toso, C Butts, H A Young, P Hwu.   

Abstract

Dendritic cells (DC) are specialized cells of the immune system responsible for the initiation and regulation of both cellular and humoral responses. DC function is highly dependent on their level of maturation. In this study, we postulated that full DC maturation would require a combination of activating signals. When cultured monocyte-derived DC received stimulation with CD40 ligand (CD40L) and lipopolysaccharide (LPS) together, the IL-12 secretion increased 5-60-fold and the IL-10 secretion increased 5-15-fold when compared with either stimulation alone. In addition, poly I.C, a double-stranded RNA analog that mimics viral infection, also synergized with CD40L to stimulate DC to secrete high levels of IL-12 and IL-10. Flow cytometry revealed an up-regulation in the expression of CD80, CD86 and CD83 following activation with a soluble trimeric form of CD40L (CD40Ls) or LPS. However, no further up-regulation was observed when both CD40Ls and LPS were used together compared with a single stimulatory signal, suggesting that there was no correlation between the expression of these markers and the level of IL-12/IL-10 secretion. Finally, specific cytotoxic T lymphocytes (CTL) were generated using DC pulsed with a modified HLA-A2-restricted peptide epitope derived from the melanoma antigen MART-1. DC activated with a combination of CD40Ls and LPS were more efficient in eliciting MART-specific reactivity compared to DC activated with CD40Ls or LPS alone. These results demonstrate that multiple maturational signals have a positive impact on the ability of DC to secrete IL-12 and IL-10 and more importantly, to generate antigen-specific T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093145     DOI: 10.1002/1521-4141(200011)30:11<3291::AID-IMMU3291>3.0.CO;2-2

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Effects of glioma cells on maturation of dendritic cells.

Authors:  Tetsuro Kikuchi; Toshiaki Abe; Tsuneya Ohno
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

2.  Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells.

Authors:  Denis Leclerc; Diane Beauseigle; Jérome Denis; Hélène Morin; Christine Paré; Alain Lamarre; Réjean Lapointe
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

3.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

4.  A plasmacytoid dendritic cell (CD123+/CD11c-) based assay system to predict contact allergenicity of chemicals.

Authors:  Seyoum Ayehunie; Maureen Snell; Matthew Child; Mitchell Klausner
Journal:  Toxicology       Date:  2009-08-07       Impact factor: 4.221

5.  Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.

Authors:  Carlos E Marroquin; Jennifer A Westwood; Rejean Lapointe; Arnold Mixon; John R Wunderlich; Dania Caron; Steven A Rosenberg; Patrick Hwu
Journal:  J Immunother       Date:  2002 May-Jun       Impact factor: 4.456

6.  Dendritic cell immunotherapy in uterine cancer.

Authors:  An Coosemans; Sandra Tuyaerts; Anke Vanderstraeten; Ignace Vergote; Frédéric Amant; Stefaan W Van Gool
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiation.

Authors:  Eui Young So; Changqi Sun; Anthony M Reginato; Patrycia M Dubielecka; Toru Ouchi; Olin D Liang
Journal:  Cancer Biol Ther       Date:  2018-10-02       Impact factor: 4.742

8.  Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells.

Authors:  D Nagorsen; M Panelli; M E Dudley; S E Finkelstein; S A Rosenberg; F M Marincola
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

9.  Lycopene suppresses the lipopolysaccharide-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB.

Authors:  Gi-Young Kim; Jong-Hyun Kim; Soon-Cheol Ahn; Hee-Jeong Lee; Dong-Oh Moon; Chang-Min Lee; Yeong-Min Park
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

10.  Inhibitory effects of progesterone differ in dendritic cells from female and male rodents.

Authors:  Cherié L Butts; Eve Bowers; J Cash Horn; Shetha A Shukair; Elena Belyavskaya; Leonardo Tonelli; Esther M Sternberg
Journal:  Gend Med       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.